Agmatine Protects Retinal Ganglion Cells from Hypoxia-Induced Damage
Author Information
Author(s): Hong Samin, Lee Jong Eun, Kim Chan Yun, Seong Gong Je
Primary Institution: Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea
Hypothesis
Agmatine has protective effects against hypoxia-induced apoptosis in retinal ganglion cells.
Conclusion
Agmatine has neuroprotective effects against hypoxia-induced retinal ganglion cell damage in RGC-5 cells.
Supporting Evidence
- Agmatine reduced hypoxia-induced cell loss from 52.3% to 25.6%.
- Agmatine treatment resulted in lower levels of apoptotic cells compared to hypoxia alone.
- Agmatine suppressed the activation of JNK and NF-κB signaling pathways.
Takeaway
Agmatine helps protect eye cells from damage caused by low oxygen levels, which can lead to cell death.
Methodology
RGC-5 cells were cultured in a hypoxic chamber and treated with agmatine; cell viability and apoptosis were assessed using LDH, annexin V, and caspase-3 assays.
Limitations
The study used immortalized RGC-5 cells instead of primary RGCs, which may not perfectly replicate in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website